首页> 外国专利> RECOMBINANT PROTEIN OFHAEMONCHUSCONTORTUS AND USE THEREOF FOR THE PRODUCTION OF A VACCINE AGAINST HAEMONCHOSIS

RECOMBINANT PROTEIN OFHAEMONCHUSCONTORTUS AND USE THEREOF FOR THE PRODUCTION OF A VACCINE AGAINST HAEMONCHOSIS

机译:嗜血杆菌 曲霉菌的重组蛋白及其在生产抗血痘疫苗中的用途

摘要

A recombinant protein (rHc23) of H. contortus was produced after establishing that the native protein Hc23, with a molecular weight of 23kDa, originating from a soluble extract from the adult haematophagous nematode H. contortus demonstrated an immunoprotective ability in young sheep of 5 months of age against the most significant trichostrongylidosis (haemonchosis) from an economic and pathological point of view. Protein Hc23 was characterised, obtaining genome and amino acid sequences of same, which, using molecular biology techniques, recombinant DNA, can be used to produce a stable protein, rHc23. The use thereof in immunogenic compositions that include, as an adjuvant, the combination of inactivated Propionibacterium acnes + lipopolysaccharide of E. coli has demonstrated a high degree of protection in animals (protection 85%).
机译:确认了一种天然蛋白Hc23,其分子量为23kDa,来自成年嗜血性线虫线虫H. contortus的可溶性提取物,在5个月龄的年轻绵羊中具有免疫保护能力,从而产生了Contortus重组蛋白(rHc23)。从经济和病理学的角度来看,最严重的毛滴虫病(年龄较大)的发病年龄。对蛋白Hc23进行了表征,获得了相同的基因组和氨基酸序列,使用分子生物学技术,重组DNA可用于生产稳定的蛋白rHc23。其在包括佐剂的灭活的痤疮丙酸杆菌+大肠杆菌脂多糖的佐剂的免疫原性组合物中的用途已显示出对动物的高度保护(保护> 85%)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号